ClinicalTrials.Veeva

Menu

COVID-19 Biological Samples Collection (COLCOV19-BX)

U

University Hospital of Bordeaux

Status

Enrolling

Conditions

Infection Viral

Treatments

Other: biological samples collection

Study type

Observational

Funder types

Other

Identifiers

NCT04332016
CHUBX 2020/11

Details and patient eligibility

About

The coronavirus disease 2019 (COVID-19) outbreak is now considered as a public health emergency of international concern by the World Health Organization.

In the context of the health emergency, research on the pathogen (the SARS-CoV-2 coronavirus), the disease and the therapeutic care is being organized. Research projects require the use of biological samples. This study aims at setting up a collection of biological samples intended for application projects in any discipline.

The main objective of the study is to collect, process and store biological samples from patients and caregivers infected with SARS-CoV-2 (COVID-19) at the biological ressources center of the Bordeaux University Hospital.

Enrollment

2,000 estimated patients

Sex

All

Ages

Under 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or symptomatic infection by SARS -CoV-2
  • men and women, adults and minors as well as pregnant or breastfeeding women
  • patients who died following infection with SARS-CoV-2 (specific criterion for post-mortem biopsies)
  • Be affiliated with or beneficiary of a social security scheme
  • Free and informed consent obtained and signed by the patient

Exclusion criteria

  • Under guardianship or curatorship

Trial design

2,000 participants in 1 patient group

COVID-19 infected patients
Treatment:
Other: biological samples collection

Trial contacts and locations

1

Loading...

Central trial contact

Aurélie POUZET; Isabelle PELLEGRIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems